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Abstract We report on a pyogenic psoas abscess secondary
to an impacted calcium oxalate ureteric stone in a 2-year-old
boy with glycogen storage disease type 1 (GSD-1). The
patient had a drainage of the abscess through a flank
incision followed by percutaneous nephrostomy and open
ureterolithotomy. Metabolic acidosis, hyperuricemia, hypo-
citraturia, and hypercalciuria appear to be significant in the
pathogenesis of urolithiasis in patients with GSD-1. Regular
ultrasonography of the abdomen along with optimal
metabolic control may delay or prevent urolithiasis and its
complications in GSD-1 patients.
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Introduction
Glycogen storage diseases are inherited disorders affecting
enzymes involved in the synthesis and degradation of
glycogen. Type 1 glycogen storage disease (GSD-1), also
known as von Gierke’s disease, is rare (incidence; 1 in
100,000 live births) and is characterized by the absence or
deficiency of glucose-6-phosphatase in the liver, kidney,
and intestinal mucosa [1, 2]. Clinical features include
growth retardation, hepatomegaly, fasting hypoglycemia,
lactic acidemia, hyperuricemia, and hyperlipidemia [1, 3,
4]. Despite advances in therapy, renal disease continues to
be an important cause of morbidity and usually determines
the long-term outcome [5]. Renal manifestations include
nephromegaly, glomerular hyperfiltration and segmental
glomerulosclerosis, and proximal and distal tubular dys-
functions causing a Fanconi-like syndrome, nephrocalci-
nosis, and nephrolithiasis [1, 3–6]. Calcium oxalate
urolithiasis is rare in GSD-1 and can lead to obstruction
and infectious complications [3, 7].
We report here a 2-year-old boy with GSD-1 who
developed psoas abscess secondary to an impacted calcium
oxalate ureteric stone and extravasation of urine from the
ureteropelvic junction.
Case report
A 2-year-old male, product of a consanguineous marriage,
presented with 15-day history of fever (39°C), abdominal
distension, and an inability to walk. According to the
parents abdominal distension dated back to early infancy,
and he was not growing well. There was no history of
trauma, gastrointestinal, or urinary symptoms. Upon
examination, he had a protuberant belly, “round doll
face”, and the height and weight were below the fifth
percentile (height: 72 cm; weight: 8.3 kg). The liver was
enlarged to 8 cm below the costal margin, and the right
lower abdomen was erythematous and tender. Ultrasonog-
raphy (US) and computerized tomography (CT) of the
abdomen showed moderate hepatosplenomegaly, an ab-
scess measuring 9.8×6.5×5.5 cm along the right psoas
region, and right-sided hydroureteronephrosis due to a
calculus in the lower ureter (Fig. 1a,b). Preliminary
investigations revealed anemia (hemoglobin: 7.1 gm/dl;
hematocrit: 23%), leukocytosis (38.3×109/l), neutrophilia
(84%), and elevated C-reactive proteins (10.4 mg/dl; normal:
0–1 mg/dl). Blood urea nitrogen, creatinine, and serum
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electrolytes were within normal limits. He received broad-
spectrum antibiotics (clindamycin: 40 mg/kg/day; amikacin:
15 mg/kg/day), and drainage of the abscess through a flank
incision revealed 120 ml of thick yellowish pus. Culture of the
pus revealed Escherichia coli. Blood and urine cultures
showed no growth of microorganisms. On the third postop-
erative day urine started leaking through the incision, and an
US-guided percutaneous nephrostomy was performed. A
contrast study showed extravasation of contrast at the ureter-
opelvic junction and a 1.5-×1.5-cm stone in the right lower
ureter (Fig. 1c). The leakage of urine stopped, and the patient
became apyrexial. Subsequent investigations revealed normal
sweat chlorides, low-fasting blood sugar (45 mg/dl), and
normal random blood sugar (120 mg/dl). The patient had
nocturnal hypoglycemic episodes and required carbohydrate
supplements. An arterial blood sample revealed lactic acidosis
(pH 7.3; lactate: 5.2 mmol/l, normal: 0.5–1.6 mmol/l; base
excess: −4.0 mmol/l, normal: −0.2 ± 2.0 mmol/l). Serum
proteins, liver function tests, and serum cholesterol were
normal, whereas serum triglycerides and total lipids were
elevated to 350 mg/dl (normal: 46–236 mg/dl) and 1234 mg/dl
(normal: 500–1000 mg/dl), respectively.
An open ureterolithotomy and liver biopsy were performed.
Histological analyses of the liver showed minimal fibrosis and
a universal distension of hepatocytes by glycogen and fat
when stained with periodic acid-Schiff (PAS). Chemical
analysis of the stone revealed a mixture of calcium (20%),
oxalate (60%), phosphate (15%), and urate (5%). Results of
further investigations were as follows. Neutrophil function
tests [phagocytic index, nitroblue tetrazolium (NBT) test]
were normal; serum uric acid was raised (8.2 mg/dl; normal:
6.5–7.5 mg/dl); sodium, potassium, calcium, phosphate, and
parathyroid hormone levels were normal; urinary pH was 6.5;
microscopy of urine sediment showed calcium oxalate and
urate crystals. A 24-h urine sample revealed hypocitraturia
(0.8 mg/kg/day; normal: >2.0 mg/kg/day), hyperuricosuria
(15.5 mg/kg/day; normal: <10.7 mg/kg/day), hypercalciuria
(7 mg/kg/day; normal: <4 mg/kg/day), and hyperoxaluria
(2.9 mg/kg/day; normal: 0.57 mg/kg/day). Allopurinol
(50 mg/day) and potassium sodium citrate (Uralyt-U;
5 gm/daily) were administered with carbohydrate and protein
supplements on a regular basis. At the 6-month follow-up,
the patient was stone-free, normoglycemic, and gaining
weight.
Discussion
Nephrocalcinosis and nephrolithiasis are not uncommon
conditions in patients with GSD-1, with a reported
incidence of up to 65% in adults with GSD-1 [8]. Renal
calcification or kidney stones were observed in 14% of
Fig. 1 a, b Computerized to-
mography (CT) scan showing a
large abscess along the right
psoas region and a lower ure-
teric stone (white arrow),
c antegrade pyelogram demon-
strating extravasation of contrast
at the pelviureteral junction
(black arrow) and the stone in
lower ureter (white arrow)
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children with a mean age of 4 years followed in a
collaborative European study [2]. The development of a
calcium oxalate stone and the complications reported here
in a patient 2 years of age is unusual. It is worth mentioning –
although it may just be a coincidence – that Pakistan, is
located in a region known as the stone belt [7]. The
contributing factors leading to urolithiasis can be chronic
acidosis, hyperuricemia, hypocitraturia, and hypercalciuria
due to the delay in diagnosing GSD-1 [1, 3, 4, 6].
Hyperuricemia and hypercalcemia were reported in 29–
33% of the patients followed in the European study [2].
Restaino et al. studied 11 patients with GSD-1 (age range:
2–24 years), and renal calculi were present in five of these
(45%): five of the 11 patients had hypercalciuria, and nine
patients had impaired renal acidification; low urinary citrate
concentration was observed in all of the patients [4].
Urinary citrate is a strong chelator of calcium oxalate and
calcium phosphate, and low urinary citrate is a recognized
cause of calcium oxalate nephrolithiasis [3, 4, 8, 9].
Hyperoxaluria of renal and dietary origin in malnourished
children can also promote calcium oxalate stone formation
[9]. Severe acidosis in patients with GSD-1 influences
urinary citrate excretion (by reduced uptake by the
proximal tubular cell in intracellular acidosis and by
directly influencing the proximal tubular transport of citrate
by the brush border membrane in response to a low luminal
pH) and causes bone dissolution and hypercalciuria [10]. In
malnourished children, low oral calcium absorption can
allow oxalate to be absorbed, and this may explain the
hypercalciuria and hyperoxaluria in the reported patient.
Periodic abdominal US is recommended in patients with
GSD-1 to detect renal calcification and liver tumors [6, 11].
There is some evidence that optimal metabolic control,
alkalization of urine, and citrate supplementation may be
beneficial in preventing or ameliorating nephrocalcinosis
and the development of urinary stones in patients with
GSD-1 [2, 11].
Stones in the urinary tract can cause obstruction and
may be a source of infection. Disruption of the ureter-
opelvic junction and the development of psoas abscess
secondary to an impacted ureteric stone are rare [7]. Psoas
abscesses in infants and children are usually due to
primary infection of the retroperitoneal lymph nodes by
Staphylococcus aureus [12]. Secondary psoas abscesses
can occur due to trauma, peritonitis, and gastrointestinal
or renal disease [13]. Psoas abscesses of renal or ureteric
etiology are unusual in children [14, 15]. A literature
review of psoas abscesses of renal etiology included only
one child, and in a series of 104 cases of non-tuberculous
psoas abscesses in children, none had underlying renal
pathology [12, 16]. To our knowledge, this is probably the
first case of pyogenic psoas abscess secondary to ureteric
lithiasis in a young patient with GSD-1. Given the
variable data available on the incidence of nephrocalci-
nosis and nephrolithiasis in patients with GSD-1, it is
difficult to propose definitive recommendations regarding
the age at which screening should be initiated. Following
the diagnosis of GSD-1, yearly US of the abdomen and
regular estimations of urine sediment, urine creatinine,
calcium, and citrate, as suggested by European study
on glycogen storage disease type I (ESGSD I), are
recommended.
In conclusion, we report a case of psoas abscess
secondary to a complicated calcium oxalate ureteric stone
in a 2-year-old child with GSD-1. Children with GSD-1 are
at increased risk for nephrocalcinosis and urolithiasis.
Regular abdominal sonography and optimal metabolic
control from an early age may delay or prevent urolithiasis
in patients having GSD-1.
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